Literature DB >> 6197257

The role of heparin in angiogenesis.

J Folkman, S Taylor, C Spillberg.   

Abstract

A series of experiments is described in which: (i) mast cells were found to accumulate at a tumour site before the ingrowth of new capillaries; (ii) heparin released by mast cells increased the migration of capillary endothelial cells in vitro; and (iii) heparin enhanced tumour angiogenesis in vivo. These experiments led to the discovery that protamine and platelet factor 4 are angiogenesis inhibitors. This finding suggests a central role for heparin or related glycosaminoglycans in the growth regulation of capillary blood vessels.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197257     DOI: 10.1002/9780470720813.ch9

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  5 in total

1.  In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis.

Authors:  S M Smorenburg; R Vink; M te Lintelo; W Tigchelaar; A Maas; H R Büller; C J van Noorden
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1.

Authors:  K A Thomas; M Rios-Candelore; G Giménez-Gallego; J DiSalvo; C Bennett; J Rodkey; S Fitzpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

3.  Early embryonic angiogenesis in the chick area vasculosa.

Authors:  W E Allen; D J Wilson
Journal:  J Anat       Date:  1993-12       Impact factor: 2.610

4.  Mast cells and angiogenesis in oral malignant and premalignant lesions.

Authors:  E Z Michailidou; A K Markopoulos; D Z Antoniades
Journal:  Open Dent J       Date:  2008-11-28

5.  Endothelial proliferation in tumours and normal tissues: continuous labelling studies.

Authors:  B Hobson; J Denekamp
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.